The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inhalers and Nebulizers Market Research Report 2025
Synopsis
Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
The global Inhalers and Nebulizers market was valued at US$ 14010 million in 2023 and is anticipated to reach US$ 18410 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
This report aims to provide a comprehensive presentation of the global market for Inhalers and Nebulizers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalers and Nebulizers.
Report Scope
The Inhalers and Nebulizers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhalers and Nebulizers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalers and Nebulizers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Chiesi
Boehringer Ingelheim
Novartis
Teva
Organon
PARI GmbH
Omron
Philips
Drive DeVilbiss Healthcare
Yuwell
Leyi
Folee
Beurer
Segment by Type
Inhalers
Nebulizer
Segment by Application
Asthma
COPD
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalers and Nebulizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalers and Nebulizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
The global Inhalers and Nebulizers market was valued at US$ 14010 million in 2023 and is anticipated to reach US$ 18410 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
This report aims to provide a comprehensive presentation of the global market for Inhalers and Nebulizers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalers and Nebulizers.
Report Scope
The Inhalers and Nebulizers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhalers and Nebulizers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalers and Nebulizers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Chiesi
Boehringer Ingelheim
Novartis
Teva
Organon
PARI GmbH
Omron
Philips
Drive DeVilbiss Healthcare
Yuwell
Leyi
Folee
Beurer
Segment by Type
Inhalers
Nebulizer
Segment by Application
Asthma
COPD
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalers and Nebulizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalers and Nebulizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Inhalers and Nebulizers Market Overview
1.1 Product Overview and Scope of Inhalers and Nebulizers
1.2 Inhalers and Nebulizers Segment by Type
1.2.1 Global Inhalers and Nebulizers Market Value Comparison by Type (2024-2030)
1.2.2 Inhalers
1.2.3 Nebulizer
1.3 Inhalers and Nebulizers Segment by Application
1.3.1 Global Inhalers and Nebulizers Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Inhalers and Nebulizers Market Size Estimates and Forecasts
1.4.1 Global Inhalers and Nebulizers Revenue 2019-2030
1.4.2 Global Inhalers and Nebulizers Sales 2019-2030
1.4.3 Global Inhalers and Nebulizers Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inhalers and Nebulizers Market Competition by Manufacturers
2.1 Global Inhalers and Nebulizers Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inhalers and Nebulizers Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inhalers and Nebulizers Average Price by Manufacturers (2019-2024)
2.4 Global Inhalers and Nebulizers Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhalers and Nebulizers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalers and Nebulizers, Product Type & Application
2.7 Inhalers and Nebulizers Market Competitive Situation and Trends
2.7.1 Inhalers and Nebulizers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhalers and Nebulizers Players Market Share by Revenue
2.7.3 Global Inhalers and Nebulizers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhalers and Nebulizers Retrospective Market Scenario by Region
3.1 Global Inhalers and Nebulizers Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inhalers and Nebulizers Global Inhalers and Nebulizers Sales by Region: 2019-2030
3.2.1 Global Inhalers and Nebulizers Sales by Region: 2019-2024
3.2.2 Global Inhalers and Nebulizers Sales by Region: 2025-2030
3.3 Global Inhalers and Nebulizers Global Inhalers and Nebulizers Revenue by Region: 2019-2030
3.3.1 Global Inhalers and Nebulizers Revenue by Region: 2019-2024
3.3.2 Global Inhalers and Nebulizers Revenue by Region: 2025-2030
3.4 North America Inhalers and Nebulizers Market Facts & Figures by Country
3.4.1 North America Inhalers and Nebulizers Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inhalers and Nebulizers Sales by Country (2019-2030)
3.4.3 North America Inhalers and Nebulizers Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalers and Nebulizers Market Facts & Figures by Country
3.5.1 Europe Inhalers and Nebulizers Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inhalers and Nebulizers Sales by Country (2019-2030)
3.5.3 Europe Inhalers and Nebulizers Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalers and Nebulizers Market Facts & Figures by Country
3.6.1 Asia Pacific Inhalers and Nebulizers Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inhalers and Nebulizers Sales by Country (2019-2030)
3.6.3 Asia Pacific Inhalers and Nebulizers Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhalers and Nebulizers Market Facts & Figures by Country
3.7.1 Latin America Inhalers and Nebulizers Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inhalers and Nebulizers Sales by Country (2019-2030)
3.7.3 Latin America Inhalers and Nebulizers Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalers and Nebulizers Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalers and Nebulizers Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inhalers and Nebulizers Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inhalers and Nebulizers Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalers and Nebulizers Sales by Type (2019-2030)
4.1.1 Global Inhalers and Nebulizers Sales by Type (2019-2024)
4.1.2 Global Inhalers and Nebulizers Sales by Type (2025-2030)
4.1.3 Global Inhalers and Nebulizers Sales Market Share by Type (2019-2030)
4.2 Global Inhalers and Nebulizers Revenue by Type (2019-2030)
4.2.1 Global Inhalers and Nebulizers Revenue by Type (2019-2024)
4.2.2 Global Inhalers and Nebulizers Revenue by Type (2025-2030)
4.2.3 Global Inhalers and Nebulizers Revenue Market Share by Type (2019-2030)
4.3 Global Inhalers and Nebulizers Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inhalers and Nebulizers Sales by Application (2019-2030)
5.1.1 Global Inhalers and Nebulizers Sales by Application (2019-2024)
5.1.2 Global Inhalers and Nebulizers Sales by Application (2025-2030)
5.1.3 Global Inhalers and Nebulizers Sales Market Share by Application (2019-2030)
5.2 Global Inhalers and Nebulizers Revenue by Application (2019-2030)
5.2.1 Global Inhalers and Nebulizers Revenue by Application (2019-2024)
5.2.2 Global Inhalers and Nebulizers Revenue by Application (2025-2030)
5.2.3 Global Inhalers and Nebulizers Revenue Market Share by Application (2019-2030)
5.3 Global Inhalers and Nebulizers Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Inhalers and Nebulizers Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Inhalers and Nebulizers Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Chiesi
6.3.1 Chiesi Corporation Information
6.3.2 Chiesi Description and Business Overview
6.3.3 Chiesi Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chiesi Inhalers and Nebulizers Product Portfolio
6.3.5 Chiesi Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim Inhalers and Nebulizers Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Inhalers and Nebulizers Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Inhalers and Nebulizers Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Organon
6.6.1 Organon Corporation Information
6.6.2 Organon Description and Business Overview
6.6.3 Organon Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Organon Inhalers and Nebulizers Product Portfolio
6.7.5 Organon Recent Developments/Updates
6.8 PARI GmbH
6.8.1 PARI GmbH Corporation Information
6.8.2 PARI GmbH Description and Business Overview
6.8.3 PARI GmbH Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.8.4 PARI GmbH Inhalers and Nebulizers Product Portfolio
6.8.5 PARI GmbH Recent Developments/Updates
6.9 Omron
6.9.1 Omron Corporation Information
6.9.2 Omron Description and Business Overview
6.9.3 Omron Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Omron Inhalers and Nebulizers Product Portfolio
6.9.5 Omron Recent Developments/Updates
6.10 Philips
6.10.1 Philips Corporation Information
6.10.2 Philips Description and Business Overview
6.10.3 Philips Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Philips Inhalers and Nebulizers Product Portfolio
6.10.5 Philips Recent Developments/Updates
6.11 Drive DeVilbiss Healthcare
6.11.1 Drive DeVilbiss Healthcare Corporation Information
6.11.2 Drive DeVilbiss Healthcare Inhalers and Nebulizers Description and Business Overview
6.11.3 Drive DeVilbiss Healthcare Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Drive DeVilbiss Healthcare Inhalers and Nebulizers Product Portfolio
6.11.5 Drive DeVilbiss Healthcare Recent Developments/Updates
6.12 Yuwell
6.12.1 Yuwell Corporation Information
6.12.2 Yuwell Inhalers and Nebulizers Description and Business Overview
6.12.3 Yuwell Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yuwell Inhalers and Nebulizers Product Portfolio
6.12.5 Yuwell Recent Developments/Updates
6.13 Leyi
6.13.1 Leyi Corporation Information
6.13.2 Leyi Inhalers and Nebulizers Description and Business Overview
6.13.3 Leyi Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Leyi Inhalers and Nebulizers Product Portfolio
6.13.5 Leyi Recent Developments/Updates
6.14 Folee
6.14.1 Folee Corporation Information
6.14.2 Folee Inhalers and Nebulizers Description and Business Overview
6.14.3 Folee Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Folee Inhalers and Nebulizers Product Portfolio
6.14.5 Folee Recent Developments/Updates
6.15 Beurer
6.15.1 Beurer Corporation Information
6.15.2 Beurer Inhalers and Nebulizers Description and Business Overview
6.15.3 Beurer Inhalers and Nebulizers Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beurer Inhalers and Nebulizers Product Portfolio
6.15.5 Beurer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalers and Nebulizers Industry Chain Analysis
7.2 Inhalers and Nebulizers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalers and Nebulizers Production Mode & Process
7.4 Inhalers and Nebulizers Sales and Marketing
7.4.1 Inhalers and Nebulizers Sales Channels
7.4.2 Inhalers and Nebulizers Distributors
7.5 Inhalers and Nebulizers Customers
8 Inhalers and Nebulizers Market Dynamics
8.1 Inhalers and Nebulizers Industry Trends
8.2 Inhalers and Nebulizers Market Drivers
8.3 Inhalers and Nebulizers Market Challenges
8.4 Inhalers and Nebulizers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
